Enwei Pharmaceutical Co., Ltd. (301331.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 20.65

From 52W high−38.31%

Volume1.14M

Market capCNY 2.25B

P/E (TTM)43.3x

P/S (TTM)2.4x

Div yield—

Key dataSep 18, 2026

Open

CNY 20.65

From 52W high

−38.31%

Volume

1.14M

Market cap

CNY 2.25B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

43.3x

RSI (14)

41.6

MomentumView details →

1D Return

−1.31%

YTD Return

−22.01%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

43.3x

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

2.4x

P/B (TTM)

2.2x

ProfitabilityView details →

Gross Margin

51.05%

Net Margin

5.47%

EBITDA Margin

12.89%

ROE (TTM)

4.43%

ROA (TTM)

3.21%

Asset Turnover

0.58x

GrowthView details →

Revenue YoY

+6.60%

EPS YoY

+4.97%

FCF YoY

−52.07%

Revenue CAGR 3Y

+9.21%

EPS CAGR 3Y

−24.86%

EBITDA YoY

—

MomentumView details →

1D Return

−1.31%

YTD Return

−22.01%

1Y Return

−38.79%

RSI (14)

41.6

vs 50D SMA

−2.79%

vs 200D SMA

−18.49%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

2.36x

Quick Ratio

2.03x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

879.60M

Net Income (TTM)

48.14M

Op. CF (TTM)

81.42M

Latest newsMore news →

Enwei Pharmaceutical's controlling shareholder Enwei Group and shareholder Chengdu Ruijin pledged 840,000 and 1.988 million shares respectively on August 25, 2026, for their own production and operation, with pledge expiry upon application for release.25d ago

Enwei Medical's controlling shareholder Enwei Group had 137,584 shares unfrozen by judicial order on July 16, 2026.66d ago

Similar companies

智迪科技301503.SZ 博菲电气001255.SZ 裕兴股份300305.SZ 海泰科301022.SZ 实丰文化002862.SZ 双箭股份002381.SZ

Latest newsMore news →

Enwei Pharmaceutical's controlling shareholder Enwei Group and shareholder Chengdu Ruijin pledged 840,000 and 1.988 million shares respectively on August 25, 2026, for their own production and operation, with pledge expiry upon application for release.25d ago Enwei Medical's controlling shareholder Enwei Group had 137,584 shares unfrozen by judicial order on July 16, 2026.66d ago